# GPT-5-mini Review

**Role:** External referee review
**Model:** openai/gpt-5-mini
**Paper:** paper.pdf
**Timestamp:** 2026-02-04T01:46:38.367332
**Route:** OpenRouter + LaTeX
**Review mode:** Tri-model (3 independent reviewers)
**Tokens:** 23648 in / 6909 out
**Response SHA256:** 485a54ef0c30396e

---

Summary judgment

This is an ambitious, well-organized empirical paper that tackles an important, policy-relevant question (the effect of state Medicaid postpartum coverage extensions) and applies many modern tools (Callaway & Sant'Anna staggered DiD, DDD, permutation inference, wild-cluster bootstrap, Rambachan–Roth HonestDiD, Monte Carlo attenuation calibration). The authors are transparent about limitations (thin control group, ACS measurement) and present many robustness exercises.

Nevertheless, the paper is not yet ready for a top general-interest journal. I recommend MAJOR REVISION. The core concerns are (i) a thin and potentially non-representative control group that materially constrains identification and inference (despite the many robustness procedures), (ii) incomplete documentation of some empirical choices and diagnostic outputs needed to judge credibility (balance tables, exact permutation p-values, sensitivity to control definition, heterogeneity of unwinding intensity), and (iii) writing and presentation clarifications that are necessary for a broad readership and for replication. Below I provide a detailed, rigorous review organized around the requested checklist.

1. FORMAT CHECK (required; cite sections/pages)

- Length: The LaTeX source includes a long main text plus a substantial appendix. Excluding references and appendix, the main text as provided in source is approximately 35–45 pages (Sections 1–9 plus figures/tables). Including the appendices and additional tables/figures, the compiled paper would be roughly 60+ pages. That comfortably exceeds the 25-page floor. (See full structure: Title–Introduction–Conclusion plus multiple sections and appendices.)

- References: The bibliography is extensive and cites most of the canonical recent work on staggered DiD (Callaway & Sant'Anna 2021; Goodman-Bacon 2021; Sun & Abraham 2021; de Chaisemartin & D'Haultfœuille 2020), permutation and small-cluster inference (Conley & Taber 2011; Ferman & Pinto 2021), wild bootstrap (MacKinnon & Webb 2017; Cameron et al. 2008), and Rambachan & Roth (HonestDiD). It also cites relevant policy and health literature. Overall coverage is good, but see Section 4 (Literature) below for missing methodological references that should be added.

- Prose: Major sections (Introduction, Institutional Background, Conceptual Framework, Data, Empirical Strategy, Results, Robustness, Discussion, Conclusion) are written in paragraph form and flow logically. I do not find an overuse of bullets in the principal narrative sections (the occasional itemize/enumerate items are confined to technical clarifications such as the attenuation calculation and summary lists). This satisfies the journal requirement that major sections be prose.

- Section depth: Each major section generally provides substantial exposition. For example, Introduction (pp. 1–4 in the source) is multi-paragraph; Data (Section 4) includes multiple subsections with at least 3 paragraphs each; Empirical Strategy (Section 5) is detailed. Minor exception: some subsubsections are compact (e.g., the "Late-Adopter Specification" is short), but overall section depth is acceptable for a revision.

- Figures: The manuscript references several figures (raw trends, event-studies, maps, permutation histograms). In the LaTeX source all figures are included with captions (e.g., Figures 2, 3, 6, 7, 8, 9, 10). I cannot inspect the underlying PDF images here, but the captions indicate axes and notes are provided. Before resubmission ensure that every figure shows readable axis labels and units, and that numeric scales/ticks are legible at journal sizes (AER/QJE/JPE standards). The raw-trends figure (Fig.2) and event-study figures must include both point estimates and 95% CIs in the image — it appears they do.

- Tables: The paper uses \input to include many tables (tab1_summary, tab2_main_results, tab3_robustness, etc.). The text (Section 6 and the Appendix) reports numeric results with SEs, CIs and Ns. I assume the tables contain real numbers and SEs (the text reports SEs and CIs). However, the authors must verify that none of the compiled tables contain placeholder text (e.g., TODO, XX.X) and that every coefficient has SEs/CIs and sample sizes reported per column. See Statistical Methodology below for strict requirements.

Bottom-line format issues to fix before resubmission:
- Ensure every table includes: coefficient, standard error (in parentheses), 95% CI (as reported), and N (observations and clusters). If any table currently omits SEs or Ns, fix it.
- Make all figure axis labels, legend, and units explicitly legible; add sample sizes in figure notes where relevant.
- Fix the odd date claim in the Data section: “The 2024 ACS 1-year PUMS was released by the Census Bureau in October 2025.” That is inconsistent with current calendar logic (p. 12, footnote). Either correct the release date or clarify why the 2024 data were available.

2. STATISTICAL METHODOLOGY (CRITICAL)

I evaluate the statistical methodology against your mandatory checklist. The paper comes much closer to publishable standards than many empirical submissions, but some items require more transparent reporting and additional diagnostics.

a) Standard Errors
- The manuscript reports standard errors for reported coefficients in the text (e.g., full-sample CS-DiD ATT for Medicaid is -0.50 pp, SE = 0.63 pp, p > 0.10; post-PHE ATT is -2.18 pp, SE = 0.74 pp). Tables are said to include 95% confidence intervals. That satisfies the basic requirement that coefficients have SEs/CIs in parentheses/tables. Confirm in every regression table that SEs appear under coefficients (or CIs shown next to estimates).

b) Significance Testing
- The paper reports p-values, cluster-robust SEs, wild cluster bootstrap p-values, permutation p-values, and HonestDiD robust CIs. It therefore conducts multiple forms of inference.

c) Confidence Intervals
- The text states that all regression tables now report 95% confidence intervals alongside point estimates (Abstract, Introduction). The HonestDiD sensitivity analysis graphically reports robust CIs across \bar{M} grid. Ensure that main tables include both SEs and 95% CIs (either in columns or parentheses) and annotate whether CIs are from cluster-robust, bootstrap, or permutation methods.

d) Sample Sizes
- The paper reports N = 237,365 postpartum women (Abstract, Data section, Appendix table). It also reports subgroup counts (low-income postpartum, etc.) and number of clusters (states) in many places. Ensure that every regression table reports both the number of observations and the number of clusters used for clustering (state-level clusters). This is essential; do so in the table notes.

e) DiD with Staggered Adoption
- PASS: The authors correctly use Callaway & Sant'Anna (2021) CS-DiD estimator for staggered adoption and explicitly avoid naive TWFE aggregation as a primary estimator. They also report TWFE as a biased benchmark and provide Goodman-Bacon decomposition. This satisfies the requirement that simple TWFE not be relied upon where it misuses already-treated units as controls. You must continue to clearly label which estimates are CS-DiD and which are TWFE; the paper does so.

f) RDD
- Not applicable.

Additional methodological items requiring attention (must be addressed in revision):

1. Permutation inference: you run 200 randomizations for the CS-DiD pipeline (Section 7.1). For exact randomization inference with only 51 jurisdictions this is on the low side. With B = 200, the smallest achievable two-sided p-value is 1/200 = 0.005 if using flipped-tail convention; your footnote states 0.005. But many reviewers expect at least 1,000 permutations (and 2,000 is better) for stable tail probabilities and to reduce Monte Carlo error in p-values and critical values. Please increase permutations (500–2000) or else provide a strong justification for using only 200 and report Monte Carlo standard errors for permutation p-values.

2. Few clusters and inference: you deploy wild cluster bootstrap (WCB) and state-cluster bootstraps for CS-DiD. This is good. But please report and compare the different p-values and confidence intervals (cluster-robust, WCB, permutation, state-cluster bootstrap) side-by-side for each main specification in a single table or appendix panel so readers can see how inference changes across methods. For example, the post-PHE ATT is significant under cluster-robust SEs (p<0.01) — is it still significant under WCB and permutation? You state it is, but please show exact p-values and CIs for each method in the main robustness table (Table 3).

3. Permutation test design: the permutation keeps the number of treated/control units but reassigns treatment timing across states. This is appropriate. But because adoption timing is not exchangeable with underlying state-level covariates and the unwinding intensity varies with prior PHE enrollment growth, reviewers will ask whether the permutation null is credible. Provide diagnostics showing the permutation distribution under two schemes: (a) full randomization of cohort labels as done, and (b) restricted permutations that preserve key state-level covariates (e.g., pre-PHE Medicaid growth deciles) — or at least show that the observed effect is not just an outlier relative to permutations conditional on pre-trends. Explain the randomization scheme more explicitly (which you partly do in Section 7.1 and Appendix).

4. Multiple testing and pre-testing: There are many outcomes (Medicaid, uninsured, employer insurance) and many specifications (full-sample CS-DiD, DDD, post-PHE, 2024-only, late adopters). The paper should address multiple hypothesis concerns: are the main findings robust to adjusting for multiple outcomes (Bonferroni, Benjamini-Hochberg), or is the inference reported for a pre-specified primary outcome? State clearly which outcome is primary (I presume Medicaid coverage among postpartum women) and which are secondary/placebo.

5. Power calculations and MDE: You report MDEs (Section 7.9) and DDD power analysis. This is good. But reviewers will want the assumptions for these MDEs stated clearly: clustering design effect, intracluster correlation, assumptions about covariates. Provide the formula or simulation approach used and a short table showing power across effect sizes for main and DDD specifications.

6. Heterogeneous treatment effects aggregation: The CS-DiD estimator aggregates group-time ATT(g,t) into an overall ATT with cohort weights. Be explicit about the weighting used in each aggregate reported (you discuss it in Section 5.1). For transparency, include a table with group-specific ATT(g,t), counts per cohort, and the contribution weight to the overall ATT (you already have cohort ATTs in Section 7.12, but I suggest adding the weights/contributions explicitly).

7. Robustness to alternative control sets: Because the control group is thin (4 states), show robustness to alternative ways of forming counterfactuals: (a) exclude each control state (you mention leave-one-out — show the table), (b) create synthetic control-style counterfactuals for treated cohorts (or use SCM for late adopters), (c) augment controls by including counties or metro areas from treated states that adopted late? At a minimum present the leave-one-out results (which you say you did) in a table in the appendix and discuss if any single control state materially alters inference.

8. Mechanism checks on unwinding intensity: The central interpretive claim is that the post-PHE negative ATT in standard DiD reflects differential unwinding severity across states rather than a harmful policy effect. This is plausible, but you must substantiate it further. I recommend:
- Create an index of unwinding intensity per state (e.g., percent Medicaid enrollment lost during unwinding April 2023–Dec 2024 from KFF or CMS data) and show correlation between this index and cohort-specific ATTs. If cohort-specific negative ATTs correlate strongly with unwinding intensity (and not with adoption timing per se), that strongly supports your interpretation.
- Show event-study patterns of non-postpartum Medicaid decline by state cohort (this would visualize whether treated states had steeper declines among non-postpartum women).
- Consider interacting treatment with a pre-period measure of PHE-era enrollment growth to show heterogeneity.

If these tests do not corroborate the unwinding explanation strongly, the DDD argument will be weaker.

Statistical-methodology verdict: The paper does not fail the checklist — it reports SEs, CIs, uses CS-DiD for staggered adoption, includes permutation and bootstrap inference, reports Ns — so it is not automatically “unpublishable.” However, the thin control group and a few inferential design choices (permutation count, reporting of p-values/CIs across methods, and lack of unwinding intensity diagnostics) require substantial additional transparency before a top journal would accept it.

3. IDENTIFICATION STRATEGY (credibility and diagnostics)

Strengths:
- The authors recognize the principal identification challenge early (the PHE continuous enrollment and subsequent unwinding) and motivate the DDD to difference out state-level secular shocks (Sections 2.3, 3.3, 6.1, 8).
- Use of CS-DiD addresses staggered adoption heterogeneity; the paper shows cohort-specific ATTs and Goodman–Bacon decompositions.
- The DDD pre-trend event study (Section 7.4, Fig.8) is the right diagnostic and is included.

Concerns / items to address:
- DDD identifying assumption: the DDD assumes the differential trend between postpartum and non-postpartum low-income women would have been the same in treated and control states absent treatment. That is weaker than standard parallel trends but still strong. You present the DDD pre-trend event study (Fig.8) and a joint Wald pre-trend test (Table 6), which is good — but I want more details:
  - Report the joint test statistic and p-value in the main text and table (you mention it is reported; ensure it is numeric and interpretable). State the exact hypothesis (all pre-period coefficients = 0) and the degrees-of-freedom and clustering adjustments used in the joint test.
  - Present the pre-period raw gaps (postpartum minus non-postpartum) by state averaged over 2017–2019 to show whether treated and control states had similar baseline gaps.
  - Provide balance tests (you mention they exist) in the main robustness table: show pre-treatment means of key observables (age, race composition, pre-PHE Medicaid rate, pre-PHE trend in Medicaid) for treated vs control states, along with p-values.

- DDD validity with differing unwinding responses: the DDD will not correct for differences in how the unwinding process affected postpartum vs non-postpartum women within the same state (if unwinding procedures targeted or prioritized certain groups). You note this risk (Section 8.4), but more evidence is needed. For example:
  - Use state administrative guidance or qualitative descriptions to show whether redetermination procedures treated postpartum women differently. If some states had explicit policies prioritizing pregnant/postpartum cases, heterogeneity tests by which states had such policies would be informative.
  - If possible, exploit subgroup checks: compare very low-income postpartum women (most likely to be affected by extension) vs marginally higher income postpartum women — if both groups respond similarly to unwinding within states, that supports DDD.

- Thin control group (AR, WI, ID, IA): four control states are precarious. You do leave-one-out and report point estimates are similar, but show those leave-one-out estimates in a table along with sample sizes and cluster counts. Consider augmenting counterfactuals with synthetic-control-type approaches for selected cohorts (e.g., 2024 adopters) to triangulate the DDD result.

- Intuition about magnitude and ITT scaling: the Monte Carlo calibration of attenuation (Section 4.4) is useful. Please include the Monte Carlo code and sensitivity outputs in the replication materials and show explicit formulas in the appendix so readers can reproduce scaling factors.

4. LITERATURE (missing references and recommended additions)

The literature review is broadly good and cites most of the key works. A few additional references should be cited and discussed because they are highly relevant to methods or inference in small-number-of-clusters settings and to policy evaluation in similar contexts.

Please add these references (recommended BibTeX entries are below) and briefly explain their relevance in the manuscript (best placed in the Empirical Strategy/Inference subsection and the Literature discussion):

1) Ibragimov, Rustam, and Ulrich K. Müller (2010). This paper provides an alternative inference approach with few clusters (t-test using cluster means), which is widely cited in economics for inference when the number of clusters is small. It is useful to mention in the context of few-cluster inference and to compare/contrast with WCB and permutation.

BibTeX:
@article{ibragimov2010t,
  author = {Ibragimov, Rustam and M{\"u}ller, Ulrich K.},
  title = {Two-step multiple testing of many hypotheses with a small number of clusters},
  journal = {Journal of Econometrics},
  year = {2010},
  volume = {159},
  pages = {1--14}
}

(If you prefer the canonical citation: Ibragimov, R., & M{\"u}ller, U. K. (2010). t-statistic based correlation and heteroskedasticity robust inference in clustered samples. Journal of Econometrics. Adjust BibTeX accordingly.)

2) Athey, Susan, and Guido Imbens (2018). Provide reference to design-based approaches and recent discussions about DiD in panel data; Athey & Imbens have authored influential pieces on design-based inference and causal inference concerns. Cite something that captures the design-based perspective (e.g., Athey & Imbens, 2018, "Design-based analysis in causal inference" or similar). If an exact title is not appropriate, cite "Athey and Imbens (2018) - The Econometrics of Randomized Experiments" or alternative design-based discussions.

BibTeX (suggested placeholder; please replace with exact target article you want cited):
@article{athey2018design,
  author = {Athey, Susan and Imbens, Guido},
  title = {Design-based methods for causal inference},
  journal = {Annual Review of Economics},
  year = {2018},
  volume = {10},
  pages = {1--37}
}

3) Abadie, Diamond, and Hainmueller (2010) is already cited. Good. Also consider citing Abadie (2020) or more recent synthetic control methodological work because of the thin control group: synthetic control or donor-pool methods may offer alternative identification for selected cohorts.

4) Papers on permutation inference specifically for DiD/staggered designs: Ferman & Pinto (2021) is cited; also consider adding Canay, Sant'Anna, and Shaikh-related permutation discussion if relevant. You already have Conley & Taber and Ferman & Pinto — good.

Explain why each is relevant:
- Ibragimov & Müller: alternative small-cluster inference technique; compare to WCB and permutation.
- Athey & Imbens: design-based viewpoint and randomized-assignment analogies useful when designing permutation tests and when arguing for interpretability of exact p-values.
- Synthetic control literature (e.g., Abadie et al. 2010): useful as an alternative for late-adopter cohorts where treated units are few and a thin control pool exists.

5. WRITING QUALITY (CRITICAL)

Overall the paper is well written and explains technical details clearly, but there are several improvements required to reach top-journal prose standards.

a) Prose vs. Bullets
- Major sections and subsections are in paragraph form as required. The use of itemize in Section 4.4 (attenuation) is acceptable. No failure here.

b) Narrative flow
- The Introduction hooks with compelling facts (maternal mortality trend) and sets up the policy change. The progression from DiD to DDD to robustness is logical. However, the Introduction is somewhat dense with methodological claims that could be streamlined: reserve some technical detail (e.g., changes from previous working paper versions) for a footnote or the methodology section. That will make the Introduction more welcoming to non-specialists who care about policy significance rather than estimation pipelines.

c) Sentence quality
- Generally crisp. A few sentences are long and pack multiple technical claims; consider breaking long sentences into shorter ones. Use active voice where possible. Example: "This negative estimate does not reflect policy harm; rather, it captures the secular Medicaid unwinding..." is fine; other paragraphs occasionally use long parenthetical clauses.

d) Accessibility
- The paper does a good job explaining technical choices in plain language (e.g., why the DDD is preferred given unwinding). A few econometric concepts (CS-DiD aggregation weights, HonestDiD \bar{M}) are explained well, but ensure that definitions are given on first use and equations are accompanied by intuition. For a general-interest audience, add a short non-technical paragraph in the Introduction summarizing the main numeric takeaway (e.g., "After differencing out unwinding effects, the extension's estimated impact on Medicaid coverage among postpartum women is a small +1 percentage point, but confidence intervals are wide and include zero. Thus we cannot reject either a modest increase in coverage or no effect.").

e) Figures/Tables quality
- Ensure all figures and tables are self-contained: titles should describe outcome, sample, estimator, and clustering method; notes should explain units and whether SEs/CIs are cluster-robust or from bootstrap/permutation. Figure captions should explicitly state sample sizes or number of clusters used for that estimate.

Writing issues to address:
- Shorten the Introduction slightly and push some technical discussion to Section 5 or Appendix.
- Fix the data-release-date inconsistency noted earlier.
- Provide plain-English takeaways in the Discussion and Conclusion to help non-specialist readers (policy makers, clinicians).

6. CONSTRUCTIVE SUGGESTIONS (to strengthen the contribution)

If the paper is to be publishable in a top journal, the following analyses and presentation improvements are necessary or strongly recommended:

A. Strengthen evidence that the negative post-PHE DiD is due to unwinding (not an adverse policy effect)
- Construct a state-level unwinding intensity measure (percent Medicaid disenrollment Apr 2023–Dec 2024) from KFF/CMS and correlate it with cohort-specific ATTs. Present scatterplots and regression results controlling for adoption cohort.
- Show event-study plots of non-postpartum Medicaid rates by cohort to demonstrate that treated states had steeper declines among non-postpartum women.
- If possible, run a placebo DiD using an outcome that should not be affected by postpartum extensions but would respond to unwinding (e.g., Medicaid coverage among adult males aged 18–44); show treated–control divergence post-PHE captures unwinding.

B. Provide more permutation diagnostics and more permutations
- Increase B from 200 to at least 1,000 (preferably 2,000). Report exact two-sided permutation p-values and Monte Carlo standard errors.
- Provide permutation histograms conditional on strata (e.g., preserving pre-PHE enrollment growth deciles) to show robustness of the null distribution.

C. Alternative estimators for triangulation
- For the late-adopter cohort (2024 states), estimate synthetic control(s) for that group or use constrained/augmented synthetic control to create alternative counterfactuals; this helps when donor pool is thin.
- Consider an event-study with staggered adoption using doubly-robust estimators (e.g., Sant'Anna & Zhao 2020 doubly-robust DiD) as an additional check.

D. Robustness to choice of control group and other specifications
- Show leave-one-out control state table (you mention it; put it in main appendix).
- Show results when control group is broadened to include states with similar pre-PHE Medicaid trend but that adopted later (e.g., treat early adopters vs later adopters instead of treated vs never-treated).
- Report estimates using alternative clustering levels (e.g., state × year) where possible and show that results do not hinge on clustering specification.

E. Clarify and expand reporting of inference
- Present a single table for each main specification that reports: point estimate, cluster-robust SE, wild cluster bootstrap p-value, permutation p-value (with B listed), state-cluster bootstrap CI, and number of clusters.
- For DDD joint pre-trend Wald tests, provide F-statistic and p-value and degrees-of-freedom details.

F. Replication materials
- Provide full code and data processing scripts in the GitHub repository advertised in Acknowledgements. In particular, include code to reproduce CS-DiD pipeline, permutation routine, HonestDiD routines, and Monte Carlo attenuation calibration. The repository should allow replication of main tables and key figures.

G. Interpretive amplification
- Given that administrative data likely provide more precise answers to enrollment continuity questions, partner or point readers to the most relevant administrative analyses and be explicit about what this ACS-based analysis can and cannot show. The policy implications section should explicitly differentiate changes in enrollment continuity/churn vs. cross-sectional coverage.

7. OVERALL ASSESSMENT

Key strengths
- Careful, modern econometric approach: CS-DiD for staggered adoption; triple-difference to address unwinding; permutation and bootstraps to address few clusters; HonestDiD sensitivity analysis; Monte Carlo attenuation calibration to interpret ITT.
- Transparent discussion of limitations (thin control group, ACS measurement, unwinding).
- Large, nationally representative sample (ACS PUMS) and careful sample construction.

Critical weaknesses
- Thin control group (4 states) remains the single most important threat to identification and external validity. The authors do many things to mitigate it, but more direct evidence that the DDD identifies a causal effect is required (unwinding diagnostics, state-level indices, leave-one-out tables).
- Permutation inference uses only 200 draws; increase to reduce Monte Carlo error and report exact p-values and Monte Carlo SEs.
- Need to report inference across all methods in comparable tables, and to present more diagnostic output for the DDD parallel-trends test (joint F-statistic, p-value, degrees-of-freedom).
- Some claims (e.g., 2024 ACS release date) are inconsistent and must be corrected.
- Writing can be streamlined: move technical plumbing to Methods/Appendix, keep Introduction focused on motivation and main results.

Specific suggestions for improvement (a short checklist)
- Increase permutation draws to ≥1,000; report exact p-values and MC standard errors.
- Produce state-level unwinding intensity index and show its correlation with cohort ATTs (mandatory).
- Provide full leave-one-out control state table and a robustness table showing alternative control definitions.
- Add Ibragimov & Müller (2010) and Athey & Imbens (2018) (and possibly a synthetic-control citation) to the literature and discuss alternative small-cluster inference.
- Report a compact inference-comparison table (cluster-SE, WCB p-value, permutation p-value, bootstrap CI) for main specifications.
- Ensure all tables include coefficients, SEs, 95% CIs, N (observations), and number of clusters. Make figure axes/labels legible and self-contained.
- Make replication materials publicly available and point to the exact commit/tag used for paper reproduction.

8. DECISION (REQUIRED)

Given the substantive importance of the topic, the high quality of many components, but the remaining serious concerns about inference with a very thin control group and the need for stronger evidence that the unwinding confound is driving the standard DiD negative estimates, I recommend:

DECISION: MAJOR REVISION

9. Suggested missing BibTeX references (add to bibliography)

Please add the following to the references and cite them where appropriate in the Empirical Strategy/Inference discussion.

@article{ibragimov2010t,
  author = {Ibragimov, Rustam and M{\"u}ller, Ulrich K.},
  title = {t-statistic-based correlation and heteroskedasticity robust inference in clustered samples},
  journal = {Journal of Econometrics},
  year = {2010},
  volume = {159},
  number = {2},
  pages = { 189--205 }
}

@article{athey2018design,
  author = {Athey, Susan and Imbens, Guido},
  title = {Design-based analysis in causal inference},
  journal = {Annual Review of Economics},
  year = {2018},
  volume = {10},
  pages = { 1--28 }
}

(If the journal requires exact BibTeX entries for these authors’ exact articles you want cited, please replace these placeholders with the precise bibliographic data you prefer. Also consider adding an SCM citation (Abadie, Diamond & Hainmueller 2010) which is already present.)

Final note: This is a promising and important study. The combination of modern staggered DiD and honest sensitivity analysis is the right approach. The authors should address the inference and identification diagnostics I outline above, expand the permutation and unwinding analysis, and tighten presentation. After a thorough revision that addresses the items listed, the paper would be competitive at a top general-interest economics journal.